# Gerardo Rosati

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gerardo-rosati/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,812 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 32 |
| i10-index | 75 |
| Last Known Institution | Ospedale San Carlo |
| OpenAlex ID | https://openalex.org/A5014792832 |
| ORCID iD | 0000-0001-7004-6862 |
| Works | 216 |

## Researcher papers

- [Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial](https://scholariq.org/papers/primary-tumor-response-to-preoperative-chemoradiation-with-or-without/)
- [A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma](https://scholariq.org/papers/a-randomized-trial-of-intensive-versus-minimal-surveillance-of-patients-with/)
- [Lapatinib in breast cancer](https://scholariq.org/papers/lapatinib-in-breast-cancer/)
- [Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial](https://scholariq.org/papers/preoperative-fluorouracil-fu-based-chemoradiation-with-and-without-weekly/)
- [Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer](https://scholariq.org/papers/duration-of-adjuvant-doublet-chemotherapy-3-or-6-months-in-patients-with-high/)
- [Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) Guideline](https://scholariq.org/papers/endoscopic-surveillance-after-surgical-or-endoscopic-resection-for-colorectal/)
- [Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma](https://scholariq.org/papers/gemcitabine-and-paclitaxel-every-2-weeks-in-patients-with-previously-untreated/)
- [Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer](https://scholariq.org/papers/randomized-trial-on-adjuvant-treatment-with-folfiri-followed-by-docetaxel-and/)
- [Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer](https://scholariq.org/papers/codon-specific-kras-mutations-predict-survival-benefit-of-trifluridine-tipiracil/)
- [FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial](https://scholariq.org/papers/folfox-or-capox-in-stage-ii-to-iii-colon-cancer-efficacy-results-of-the-italian/)
- [Does Family Caregiver Burden Differ Between Elderly and Younger Caregivers in Supporting Dying Patients With Cancer? An Italian Study](https://scholariq.org/papers/does-family-caregiver-burden-differ-between-elderly-and-younger-caregivers-in/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Colorectal Cancer Surgical Treatments](https://scholariq.org/topics/colorectal-cancer-surgical-treatments/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)

## Researcher university

- [Ospedale San Carlo](https://scholariq.org/institutions/ospedale-san-carlo/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.